WallStreetZenWallStreetZen

NASDAQ: BCAX
Bicara Therapeutics Inc Stock Ownership - Who owns Bicara Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Bicara Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Lara MeisnerChief Legal Officer2025-06-1615,829$5.45
$86.27kBuy
Lara MeisnerChief Legal Officer2025-06-1615,829$10.43
$165.10kSell
Lara MeisnerChief Legal Officer2025-03-1479,146$5.45
$431.35kSell
Lara MeisnerChief Legal Officer2025-03-1448,526$12.69
$615.70kSell
Lara MeisnerChief Legal Officer2025-03-1430,620$13.24
$405.50kSell
James E. Flynn10% Owner2024-09-1735,000$18.00
$630.00kBuy
James E. Flynn10% Owner2024-09-1735,000$18.00
$630.00kBuy
Ra Capital Management LPDirector2024-09-16152,480$18.00
$2.74MBuy
Ra Capital Management LPDirector2024-09-161,680,520$18.00
$30.25MBuy

1 of 1

BCAX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BCAX insiders and whales buy or sell their stock.

BCAX Shareholders

What type of owners hold Bicara Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP12.75%6,955,993$80.83MInstitution
Kiran Mazumdarshaw11.54%6,297,854$73.18MInsider
Biocon Ltd10.12%5,523,897$64.19MInsider
Siren LLC9.56%5,216,969$60.62MInstitution
Vestal Point Capital LP9.16%5,000,000$58.10MInstitution
Red Tree Management LLC5.81%3,170,509$36.84MInstitution
Tpg GP A LLC5.52%3,010,425$34.98MInstitution
Ra Capital Management LP4.86%2,652,575$30.82MInsider
Fmr LLC4.65%2,538,404$29.50MInstitution
Deep Track Capital LP4.45%2,426,657$28.20MInstitution

1 of 3

BCAX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BCAX70.79%29.21%Net BuyingNet Buying
BBOT27.36%54.31%Net BuyingNet Buying
TERN80.34%19.66%Net BuyingNet Buying
KROS71.32%28.68%Net BuyingNet Selling
SEPN66.18%33.82%Net BuyingNet Buying
View Top Biotech Stocks

Bicara Therapeutics Stock Ownership FAQ

Who owns Bicara Therapeutics?

Bicara Therapeutics (NASDAQ: BCAX) is owned by 93.77% institutional shareholders, 38.69% Bicara Therapeutics insiders, and 0.00% retail investors. Kiran Mazumdarshaw is the largest individual Bicara Therapeutics shareholder, owning 6.30M shares representing 11.54% of the company. Kiran Mazumdarshaw's Bicara Therapeutics shares are currently valued at $73.18M.

If you're new to stock investing, here's how to buy Bicara Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.